iRoot BP Plus冠髓切断术治疗乳磨牙部分不可复性牙髓炎的回顾性研究

doi:10.7518/hxkq.2024.2023308

华西口腔医学杂志 ›› 2024, Vol. 42 ›› Issue (2): 242-248.doi: 10.7518/hxkq.2024.2023308

iRoot BP Plus冠髓切断术治疗乳磨牙部分不可复性牙髓炎的回顾性研究

胡晓燕¹(), 赵春晖¹, 王璐², 张正³, 杨帆², 张红艳²

^1.安徽医科大学口腔医学院，安徽医科大学附属口腔医院儿童口腔科，安徽省口腔疾病研究中心实验室，合肥 230032
^2.安徽医科大学口腔医学院，安徽医科大学附属口腔医院牙体牙髓科，安徽省口腔疾病研究中心实验室，合肥 230032
^3.安徽医科大学口腔医学院，安徽医科大学附属口腔医院放射科，安徽省口腔疾病研究中心实验室，合肥 230032

收稿日期:2023-09-15 修回日期:2024-01-22 出版日期:2024-04-01 发布日期:2024-03-26
通讯作者: 胡晓燕 E-mail:273640765@qq.com
作者简介:胡晓燕，副教授，硕士，E-mail：273640765@qq.com
基金资助:
2023年度安徽省高校自然科学研究项目(2023AH0506-)

A retrospective study on iRoot BP Plus full pulpotomy for primary molars with partial irreversible pulpitis

Hu Xiaoyan¹(), Zhao Chunhui¹, Wang Lu², Zhang Zheng³, Yang Fan², Zhang Hongyan²

^1.Dept. of Pediatric Dentistry, Stomatologic Hospital & College, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei 230032, China
^2.Dept. of Endodontics, Stomatologic Hospital & College, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei 230032, China
^3.Dept. of Radiology, Stomatologic Hospital & College, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei 230032, China

Received:2023-09-15 Revised:2024-01-22 Online:2024-04-01 Published:2024-03-26
Contact: Hu Xiaoyan E-mail:273640765@qq.com
Supported by:
Natural Science Research Project of Anhui Educational Committee(2023AH050622)

摘要/Abstract

摘要：

目的回顾性观察iRoot BP Plus冠髓切断术治疗乳磨牙部分不可复性牙髓炎的临床疗效。方法收集2019年1月—2023年8月行乳磨牙iRoot BP Plus冠髓切断术治疗且随访24~47个月的部分不可复性牙髓炎病例102例，根据术前有无不可复性牙髓炎症状将纳入病例分为无症状组（n=53）和有症状组（n=49），观察两组的临床和影像学成功率。结果无症状组和有症状组的临床成功率分别为96.2%和97.9%，影像学成功率分别为96.2%和93.9%。结论在高抗菌等级前提下，iRoot BP Plus冠髓切断术可以尝试用于治疗乳磨牙部分不可复性冠髓炎。

关键词: 不可复性牙髓炎, 部分不可复性牙髓炎, iRoot BP Plus, 冠髓切断术, 乳磨牙

Abstract:

Objective This study aimed to observe the outcomes of iRoot BP Plus full pulpotomy in primary molars with partial irreversible pulpitis retrospectively. Methods Collect 102 cases of primary molars with partial irreversible pulpitis undergoing iRoot BP Plus full pulpotomy from January 2019 to August 2023, with a follow-up period of 24-47 months. Based on the presence of irreversible pulpitis symptoms before surgery, the included cases will be divided into asymptomatic group (n=53) and symptomatic group (n=49). Observe the clinical and imaging success rates of both groups. Results Clinical success rates were 96.2% and 97.9% in asymptomatic and symptomatic groups, and radiographic success rates were 96.2% and 93.9% respectively. Conclusion iRoot BP Plus full pulpotomy can be used for the treatment of primary molars with partial irreversible pulpitis under an enhanced pulpotomy protocol.

Key words: irreversible pulpitis, partial irreversible pulpitis, iRoot BP Plus, pulpotomy, primary molar

中图分类号:

R788

胡晓燕, 赵春晖, 王璐, 张正, 杨帆, 张红艳. iRoot BP Plus冠髓切断术治疗乳磨牙部分不可复性牙髓炎的回顾性研究[J]. 华西口腔医学杂志, 2024, 42(2): 242-248.

Hu Xiaoyan, Zhao Chunhui, Wang Lu, Zhang Zheng, Yang Fan, Zhang Hongyan. A retrospective study on iRoot BP Plus full pulpotomy for primary molars with partial irreversible pulpitis[J]. West China Journal of Stomatology, 2024, 42(2): 242-248.

图/表 4

表 1

表 2

图 1

图 2

参考文献 28

1	周学东. 牙体牙髓病学[M]. 5版.北京: 人民卫生出版社, 2020: 167.
	Zhou XD. Operative dentistry and endodontics[M]. 5th ed. Beijing: People’s Medical Publishing House, 2020: 167.
2	AAE position statement on vital pulp therapy[J]. J Endod, 2021, 47(9): 1340-1344.
3	Guideline on pulp therapy for primary and immature permanent teeth[J]. Pediatr Dent, 2016, 38(6): 280-288.
4	Duncan HF, Galler KM, Tomson PL, et al. European Society of Endodontology position statement: management of deep caries and the exposed pulp[J]. Int Endod J, 2019, 52(7): 923-934.
5	Ricucci D, Loghin S, Siqueira JF Jr. Correlation bet-ween clinical and histologic pulp diagnoses[J]. J Endod, 2014, 40(12): 1932-1939.
6	Asgary S, Eghbal MJ, Ghoddusi J. Two-year results of vital pulp therapy in permanent molars with irreversible pulpitis: an ongoing multicenter randomized clinical trial[J]. Clin Oral Invest, 2014, 18(2): 635-641.
7	Asgary S, Eghbal MJ, Fazlyab M, et al. Five-year results of vital pulp therapy in permanent molars with irrever-sible pulpitis: a non-inferiority multicenter randomized clinical trial[J]. Clin Oral Invest, 2015, 19(2): 335-341.
8	Taha NA, Khazali MA. Partial pulpotomy in mature permanent teeth with clinical signs indicative of irreversible pulpitis: a randomized clinical trial[J]. J Endod, 2017, 43(9): 1417-1421.
9	Taha NA, Abdulkhader SZ. Full pulpotomy with biodentine in symptomatic young permanent teeth with carious exposure[J]. J Endod, 2018, 44(6): 932-937.
10	Uesrichai N, Nirunsittirat A, Chuveera P, et al. Partial pulpotomy with two bioactive cements in permanent tee-th of 6- to 18-year-old patients with signs and symptoms indicative of irreversible pulpitis: a noninferiority randomized controlled trial[J]. Int Endod J, 2019, 52(6): 749-759.
11	彭楚芳, 赵玉鸣, 杨媛, 等. 三氧化矿物凝聚体牙髓切断术治疗年轻恒牙不可复性牙髓炎的初步研究[J]. 中华口腔医学杂志, 2015, 50(12): 715-719.
	Peng CF, Zhao YM, Yang Y, et al. Mineral trioxide aggragate pulpotomy for the treatment of immature permanent teeth with irreversible pulpitis: a preliminary clinical study[J]. Chin J Stomatol, 2015, 50(12): 715-719.
12	肖文, 史文涛, 汪俊. 炎性活髓保存在年轻恒牙不可逆性牙髓炎及根尖周炎治疗中的应用[J]. 中华口腔医学杂志, 2022, 57(3): 287-291.
	Xiao W, Shi WT, Wang J. Study of vital inflamed pulp therapy in immature permanent teeth with irreversible pulpitis and apical periodontitis[J]. Chin J Stomatol, 2022, 57(3): 287-291.
13	Linsuwanont P, Wimonsutthikul K, Pothimoke U, et al. Treatment outcomes of mineral trioxide aggregate pul-potomy in vital permanent teeth with carious pulp exposure: the retrospective study[J]. J Endod, 2017, 43(2): 225-230.
14	Asgary S, Eghbal MJ. Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis using biomaterials: a multi-center randomized controlled trial[J]. Acta Odontol Scand, 2013, 71(1): 130-136.
15	Taha NA, Abdelkhader SZ. Outcome of full pulpotomy using Biodentine in adult patients with symptoms indicative of irreversible pulpitis[J]. Int Endod J, 2018, 51(8): 819-828.
16	Asgary S, Eghbal MJ, Bagheban AA. Long-term outcomes of pulpotomy in permanent teeth with irreversible pulpitis: a multi-center randomized controlled trial[J]. Am J Dent, 2017, 30(3): 151-155.
17	Smith AJ, Duncan HF, Diogenes A, et al. Exploiting the bioactive properties of the dentin-pulp complex in regenerative endodontics[J]. J Endod, 2016, 42(1): 47-56.
18	Memarpour M, Fijan S, Asgary S, et al. Calcium-enriched mixture pulpotomy of primary molar teeth with irreversible pulpitis. A clinical study[J]. Open Dent J, 2016, 10: 43-49.
19	Asgary S, Sarraf Shirazi A, Sabbagh S. Management of primary molars with irreversible pulpitis employing tampon pulpotomy: report of three cases with 34-month mean follow-up[J]. Clin Case Rep, 2021, 9(4): 2289-2294.
20	Ricucci D, Siqueira JF Jr, Li Y, et al. Vital pulp therapy: histopathology and histobacteriology-based guidelines to treat teeth with deep caries and pulp exposure[J]. J Dent, 2019, 86: 41-52.
21	Aaminabadi NA, Parto M, Emamverdizadeh P, et al. Pulp bleeding color is an indicator of clinical and histohematologic status of primary teeth[J]. Clin Oral Investig, 2017, 21(5): 1831-1841.
22	Wolters WJ, Duncan HF, Tomson PL, et al. Minimally invasive endodontics: a new diagnostic system for assessing pulpitis and subsequent treatment needs[J]. Int Endod J, 2017, 50(9): 825-829.
23	Rajasekharan S, Martens LC, Vandenbulcke J, et al. Efficacy of three different pulpotomy agents in primary molars: a randomized control trial[J]. Int Endod J, 2017, 50(3): 215-228.
24	Çelik BN, Mutluay MS, Arıkan V, et al. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth[J]. Clin Oral Investig. 2019, 23(2): 661-666.
25	Rao Q, Kuang J, Mao C, et al. Comparison of iRoot BP Plus and calcium hydroxide as pulpotomy materials in permanent incisors with complicated crown fractures: a retrospective study[J]. J Endod, 2020, 46(3): 352-357.
26	Yang Y, Xia B, Xu Z, et al. The effect of partial pulpotomy with iRoot BP Plus in traumatized immature permanent teeth: a randomized prospective controlled trial[J]. Dent Traumatol, 2020, 36(5): 518-525.
27	Hu X, Li Y, Xu J, et al. Immature permanent incisors with complicated crown fractures treated with partial pulpotomy using white mineral trioxide aggregate and IRoot BP plus-a retrospective long-term study[J]. Dent Traumatol, 2023, 39(2): 165-172.
28	Hafez AA, Cox CF, Tarim B, et al. An in vivo evaluation of hemorrhage control using sodium hypochlorite and direct capping with a one- or two-component adhesive system in exposed nonhuman primate pulps[J]. Quintessence Int, 2002, 33(4): 261-272.

变量	无症状组	有症状组	P值
性别/n（%）			0.173
男	22（41.5）	27（55.1）
女	31（58.5）	22（44.9）
年龄/岁	5.11±1.05	5.04±1.13	0.301
牙位/n（%）			0.185
第一乳磨牙	18（34.0）	23（46.9）
第二乳磨牙	35（66.0）	26（53.1）
冠髓外观/n（%）			0.235
良好	29（54.7）	21（42.9）
不佳	24（45.3）	28（57.1）
修复体类型/n（%）			0.186
树脂	39（73.6）	30（61.2）
预成冠	14（26.4）	19（38.8）
继发龋/n（%）			0.740
有	10（18.9）	8（16.3）
无	43（81.1）	41（83.7）
随访期/月	25.02±0.28	25.60±1.54	0.371

序列	组别	性别	年龄/岁	牙位	冠髓外观	修复体类型	继发龋	随访期/月	失败表现
1	无症状组	女	4	85	不佳	树脂	有	24	根尖周病变
2	无症状组	男	4	85	不佳	树脂	无	25	根尖周病变
3	有症状组	男	4	84	良好	树脂	无	24	根吸收
4	有症状组	女	6	84	不佳	树脂	无	26	根吸收
5	有症状组	女	6	85	良好	树脂	有	26	根吸收

[1]	汪俊. 不可复性牙髓炎恒牙的活髓保存治疗[J]. 华西口腔医学杂志, 2023, 41(6): 622-627.
[2]	曲卫国王颖丰鑫. 第二乳磨牙与第二前磨牙易位埋伏阻生1例[J]. 华西口腔医学杂志, 2014, 32(1): 99-100.
[3]	杨晓琼林居红. 伴恒牙缺失和锥形侧切牙的多颗乳磨牙下沉1例[J]. 华西口腔医学杂志, 2013, 31(4): 434-435.

iRoot BP Plus冠髓切断术治疗乳磨牙部分不可复性牙髓炎的回顾性研究

A retrospective study on iRoot BP Plus full pulpotomy for primary molars with partial irreversible pulpitis

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 4

参考文献 28

相关文章 3

编辑推荐

Metrics

本文评价